Correction To: Switching From Natalizumab to Fingolimod Treatment in Multiple Sclerosis: Real Life Data From the Austrian MS Treatment Registry
Journal of Neurology - Germany
doi 10.1007/s00415-019-09535-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 17, 2019
Authors
Publisher
Springer Science and Business Media LLC